Richard L. Piekarz,
Robin Frye,
Maria Turner,
John J. Wright,
Steven L. Allen,
Mark H. Kirschbaum,
Jasmine Zain,
H. Miles Prince,
John P. Leonard,
Larisa J. Geskin,
Craig Reeder,
David Joske,
William D. Figg,
Erin R. Gardner,
Seth M. Steinberg,
Elaine S. Jaffe,
Maryalice Stetler-Stevenson,
Stephen Lade,
A. Tito Fojo,
Susan E. Bates,
- Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. Piekarz, R.L., Frye, R., Turner, M., Wright, J.J., Allen, S.L., Kirschbaum, M.H., Zain, J., Prince, H.M., Leonard, J.P., Geskin, L.J., Reeder, C., Joske, D., Figg, W.D., Gardner, E.R., Steinberg, S.M., Jaffe, E.S., Stetler-Stevenson, M., Lade, S., Fojo, A.T., Bates, S.E. J. Clin. Oncol. (2009)